当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Neuropharmacology杂志
Neuropharmacology
基本信息
期刊名称 Neuropharmacology
NEUROPHARMACOLOGY
期刊ISSN 0028-3908
期刊官方网站 https://www.sciencedirect.com/journal/neuropharmacology
是否OA No
出版商 Elsevier Ltd
出版周期 Semimonthly
文章处理费 登录后查看
始发年份 1970
年文章数 230
影响因子 4.6(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 NEUROSCIENCES 神经科学2区
PHARMACOLOGY & PHARMACY 药学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 10.0 1.489 1.105
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
36/313 88%
Neuroscience
Cellular and Molecular Neuroscience
16/97 84%
补充信息
自引率 4.3%
H-index 150
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0028-3908%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/NEUROPHARM
收稿范围
Neuropharmacology publishes high quality, original research within the discipline of neuroscience. The emphasis of Neuropharmacology is on the study and understanding of the actions of known exogenous and endogenous chemical agents on neurobiological processes in the mammalian nervous system. Work with non-mammalian and invertebrate species may be considered in exceptional circumstances. The journal does not usually accept clinical research, although neuropharmacological studies in humans may be considered on the condition that they provide novel insight into either the actions of drugs and/or neurobiological mechanisms. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Similarly, manuscripts describing the use of natural products will only be considered if the active ingredient is known and disclosed.


The journal publishes Special Issues in which leading experts are invited to serve as Guest Editors to compile a collection of reviews, and occasionally original articles, around a particular topical theme in neuroscience research. The list of recent Special Issues can be found here. Suggestions for Special Issues can be made directly to the Editor-in-Chief.

Neuropharmacology also publishes topical narrative reviews on subjects within its remit. These reviews are commissioned by the Editorial Team or arise after correspondence with potential authors. Unsolicited reviews will be considered, but authors are encouraged to contact the Editor-in-Chief of their intention to submit a review. Potential review authors should clearly indicate their expertise in the area, and how the review differs from, and adds to, recent published reviews on related topics. On the basis of the case made by authors, potential overlap with planned Neuropharmacology content, and discussions with the Editorial Team, the Editor-in-Chief will provide authors with a prompt decision regarding the proposed review. Systematic reviews, meta- or bibliographic analyses will not be considered unless they are a necessary part of a Special Issue and conducted by experts in the field, and even then only under exceptional circumstances and at the discretion of the Editor-in-Chief.
收录体裁
投稿指南 https://www.sciencedirect.com/journal/neuropharmacology/publish/guide-for-authors
投稿模板
参考文献格式 https://www.elsevier.com/journals/neuropharmacology/0028-3908/guide-for-authors
编辑信息

Editor-in-Chief

Bruno Frenguelli

University of Warwick, Coventry, England, United Kingdom Email Bruno Frenguelli

Senior Editors

Stuart Allan

The University of Manchester, Manchester, United Kingdom

Ángeles Almeida

University of Salamanca, Salamanca, Spain

Detlev Boison

Rutgers Brain Health Institute, Piscataway, New Jersey, United States

John Cryan

University College Cork National University of Ireland, Cork, Ireland

Fernanda G. De Felice

Queen's University, Kingston, Ontario, Canada

Thérèse Di Paolo

Laval University, Quebec, Canada

Thomas Gould

Pennsylvania State University, University Park, Pennsylvania, United States

Michaela Kress

Medical University of Innsbruck Institute of Physiology, Innsbruck, Austria

Christopher Parsons

Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany

Marisa Roberto

Scripps Research Institute, La Jolla, California, United States

David Slattery

Goethe University Frankfurt, Frankfurt am Main, Germany

Igor Spigelman

UCLA School of Dentistry, Los Angeles, California, United States

Jared Young

University of California San Diego, La Jolla, California, United States

Editorial Board Members

Nii Addy

YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, Connecticut, United States

Carine Ali

Pathophysiology and Imaging of Neurological Disorders, Caen, France

Vaishali Bakshi

University of Wisconsin Madison, Madison, Wisconsin, United States

Brian Baldo

University of Wisconsin Madison School of Medicine and Public Health, Madison, Wisconsin, United States

Nicholas Barnes

University of Birmingham, Birmingham, United Kingdom

Frank Barone

Suny Downstate Medical Center Department of Physiology and Pharmacology, New York, New York, United States

Alasdair Barr

The University of British Columbia, Vancouver, British Columbia, Canada

Michael H. Baumann

National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland, United States

Catherine Belzung

University of Tours, Tours, France

Angelique Bordey

YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, Connecticut, United States

Amy Brewster

Purdue University, West Lafayette, Indiana, United States

Jonathan Brigman

University of New Mexico School of Medicine, Albuquerque, New Mexico, United States

Michael Bruchas

Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, United States

Adriaan Bruijnzeel

University of Florida, Gainesville, Florida, United States

Maarten van den Buuse

The Florey Institute of Neuroscience and Mental Health, Parkville, Australia

Regina Carelli

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Eero Castren

University of Helsinki, Helsinki, Finland

Guiquan Chen

Nanjing University, Nanjing, China

Jiang-Fan Chen

Wenzhou Medical University School of Optometry and Ophthalmology, Wenzhou, China

Gerard Clarke

University College Cork National University of Ireland, Cork, Ireland

María Isabel Colado

Complutense University of Madrid, Madrid, Spain

Jeff Conn

VANDERBILT UNIVERSITY MEDICAL CENTER, Nashville, Tennessee, United States

Anis Contractor

Northwestern University Department of Physiology, Chicago, Illinois, United States

Mark Cunningham

University of Dublin Trinity College, Dublin, Ireland

Anne-Marie van Dam

VU Amsterdam, Amsterdam, Netherlands

Ceri Davies

GlaxoSmithKline Pte Ltd, Singapore, Singapore

Mariella De Biasi

Ruth and Raymond Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States

Chris Dulla

Tufts University, Medford, Massachusetts, United States

Fabrizio Gasparini

Novartis Pharma AG, Basel, Switzerland

Carla Ghelardini

University of Florence, Firenze, Italy

Nicholas Gilpin

LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER, New Orleans, Louisiana, United States

Robert Greene

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, Dallas, Texas, United States

Karen Gregory

Monash Institute of Pharmaceutical Sciences, Parkville, Australia

David Heal

RenaSci Ltd, Nottingham, United Kingdom

Andrew Holmes

National Institute on Alcohol Abuse and Alcoholism Laboratory of Behavioral and Genomic Neuroscience, Rockville, Maryland, United States

Christian Hölscher

Henan University of Traditional Chinese Medicine, Zhengzhou, China

Yasmin Hurd

Icahn School of Medicine at Mount Sinai, Department of Psychiatry, Friedman Brain Institute, New York, New York, United States

Peter Hutson

Shire Pharmaceuticals Chesterbrook, Wayne, Pennsylvania, United States

Peter Illes

University of Leipzig Institute of Pharmacology Pharmacy and Toxicology, Leipzig, Germany

Carrie Jones

Vanderbilt University School of Medicine, Nashville, Tennessee, United States

Thomas Kash

University of North Carolina at Chapel Hill School of Medicine, Asheville, North Carolina, United States

Áine Kelly

University of Dublin Trinity College, Dublin, Ireland

Paul Kenny

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Steven Gregory Kinsey

West Virginia University, Morgantown, West Virginia, United States

Wolfgang Löscher

University of Veterinary Medicine Hannover, Hannover, Germany

David Lovinger

National Institute on Alcohol Abuse and Alcoholism Rockville Office, Rockville, Maryland, United States

Ken Mackie

Indiana University Bloomington Department of Psychological and Brain Sciences, Bloomington, Indiana, United States

Rafael Maldonado

Pompeu Fabra University, Barcelona, Spain

Robert Malenka

Stanford Neurosciences Institute, Stanford, California, United States

Olivier Manzoni

Mediterranean Institute of Neurobiology, Marseille, France

Hélène Marie

Institute of Molecular and Cellular Pharmacology, Valbonne, France

Francesco Matrisciano

University of Illinois at Chicago, Chicago, Illinois, United States

Chris McBain

National Institutes of Health, Bethesda, Maryland, United States

Daniel McGehee

University of Chicago, Chicago, Illinois, United States

Lisa M. Monteggia

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, Dallas, Texas, United States

Stephen Moss

University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States

Ferdinando Nicoletti

University of Catania Department of Biomedical and Biotechnological Sciences, Catania, Italy

M. Foster Olive

Arizona State University, Tempe, Arizona, United States

Olivia O’Leary

University College Cork National University of Ireland, Cork, Ireland

Menelas Pangolas

Pfizer Global Research and Development, Princeton, New Jersey, United States

Andrzej Pilc

Institute of Pharmacology of the Polish Academy of Sciences, Krakow, Poland

Graziano Pinna

University of Illinois at Chicago, Chicago, Illinois, United States

Anna Pittaluga

University of Genoa Department of Pharmacy, Genoa, Italy

Victoria Risbrough

University of California San Diego Department of Psychology, La Jolla, California, United States

Michael Robinson

University of Pennsylvania Department of Pharmacology, Philadelphia, Pennsylvania, United States

Stephanie Schorge

University College London Institute of Neurology, London, United Kingdom

Nicolas Singewald

University of Innsbruck, Innsbruck, Austria

Nuno Sousa

University of Minho, Braga, Portugal

Yael Stern-Bach

Hebrew University Hadassah Medical School, Yerushalayim, Israel

Per Svenningsson

Karolinska Institute, Stockholm, Sweden

Andrew Tapper

University of Massachusetts Medical School, Worcester, Massachusetts, United States

Scott Thompson

University of Maryland School of Medicine, Baltimore, Maryland, United States

Lawrence Toll

Torrey Pines Institute for Molecular Studies, Port St. Lucie, Florida, United States

Henning Ulrich

University of Sao Paulo Department of Biochemistry, São Paulo, Brazil

Vidita Vaidya

Tata Institute of Fundamental Research, Mumbai, India

Cinzia Volontè

Santa Lucia Foundation Institute for Hospitalization and Care Scientific, Roma, Italy

Mark Wall

University of Warwick, Coventry, United Kingdom

Gregers Wegener

Aarhus University, Aarhus, Denmark

Danny Winder

Vanderbilt University School of Medicine, Nashville, Tennessee, United States

Marina E. Wolf

Oregon Health & Science University Department of Behavioral Neuroscience, Portland, Oregon, United States

Bryan Yamamoto

Indiana University School of Medicine, Indianapolis, Indiana, United States

Tang Yong

Chengdu University of Traditional Chinese Medicine, Chengdu, China

Xiang Yu

Institute of Neuroscience Chinese Academy of Sciences, Shanghai, China

Xiongwei Zhu

Case Western Reserve University School of Medicine, Cleveland, Ohio, United States


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug